Boothbay Fund Management’s Strata Critical Medical Inc SRTA Stock Holding History

Boothbay Fund Management’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.81M	Sell	343,014 -110,868	-24%	-$583K	0.02%	772
2026 Q1	$1.9M	Buy	453,882 +104,929	+30%	+$505K	0.02%	650
2025 Q4	$1.68M	Buy	348,953 +48,184	+16%	+$233K	0.03%	622
2025 Q3	$1.52M	Buy	300,769 +20,769	+7%	+$91.8K	0.02%	669
2025 Q2	$1.13M	Sell	280,000 -3,722	-1%	-$12.1K	0.02%	650
2025 Q1	$775K	Buy	283,722 +173,722	+158%	+$623K	0.02%	712
2024 Q4	$468K	Sell	110,000 -99,955	-48%	-$381K	0.01%	907
2024 Q3	$617K	Buy	209,955 +157,889	+303%	+$503K	0.01%	918
2024 Q2	$181K	Buy	+52,066	New	+$174K	﹤0.01%	1304
2023 Q1	–	Sell	-143,493	Closed	-$514K	–	2142
2022 Q4	$514K	Buy	+143,493	New	+$613K	0.01%	1169

Other funds holding SRTA

Third Point New York $4.68B AUM 37.3% 1-Year Est. Return

NRCM

Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

PLC

Pillsbury Lake Capital San Francisco, California $366M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boothbay Fund Management's SRTA Position: Q2 2026 in Review

Boothbay Fund Management reduced its Strata Critical Medical Inc (SRTA) stake by 24% in Q2 2026, selling an estimated $583K and leaving 343,014 shares worth $1.81M. The position accounts for 0.02% of the portfolio, ranked #772.

Boothbay Fund Management first reported a position in SRTA in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.9M in Q1 2026. 140 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

Boothbay Fund Management held 343,014 shares of Strata Critical Medical Inc worth $1.81M as of Q2 2026.
Boothbay Fund Management sold 110,868 Strata Critical Medical Inc shares in Q2 2026, an estimated $583K.
Strata Critical Medical Inc made up 0.02% of Boothbay Fund Management's portfolio in Q2 2026, its #772 holding.
Boothbay Fund Management first reported a position in Strata Critical Medical Inc in Q4 2022 and has held it in 10 quarters since.
Boothbay Fund Management's Strata Critical Medical Inc position peaked at $1.9M in Q1 2026.
140 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.